SCHEMBL6223923

SCHEMBL6223923

CCCCOC(=O)N1CCC(Br)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ LMNA P02545 1/20 0.59
▸ POLB P06746 1/20 0.59
▸ GAA P10253 1/20 0.46
▸ ATM Q13315 2/20 0.43
▸ THRB P10828 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ HRH2 P25021 1/20 0.41
▸ HRH1 P35367 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ CHRM1 P11229 2/20 0.41
▸ CHRM2 P08172 1/20 0.41
▸ NOS3 P29474 1/20 0.41
▸ NOS2 P35228 1/20 0.41
▸ HPGD P15428 1/20 0.40
▸ MMP13 P45452 2/20 0.40
▸ MMP2 P08253 1/20 0.40
▸ MMP3 P08254 1/20 0.40
▸ MMP9 P14780 1/20 0.40
▸ MMP8 P22894 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7449135 0.86 POLB (0.63) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL7339506 0.85 LMNA (0.61) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL184778 0.85 LMNA (0.61) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL27993011 0.84 GAA (0.62) SMN1; SMN2POLBGAAATMTHRB
SCHEMBL30510136 0.84 SMN1; SMN2 (0.56) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL9405372 0.84 POLB (0.73) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL856302 0.83 SMN1; SMN2 (0.59) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL30297472 0.83 LMNA (0.59) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL5156110 0.83 LMNA (0.59) SMN1; SMN2LMNAPOLBGAAATM
SCHEMBL29780696 0.83 LMNA (0.54) SMN1; SMN2LMNAPOLBATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126840-A1 ARYL PIPERIDINES AS MONOACYLGLYCEROL LIPASE MODULATORS Janssen Pharmaceutica NV (BE) 2023-02-08 — — EP disclosed
EP-4100008-A1 PYRROLO [2,3-B]PYRIDINE-3-CARBOXAMIDE COMPOSITIONS AND METHODS FOR AMELIORATING HEARING LOSS The Rockefeller University (US) 2022-12-14 — — EP disclosed
EP-3986887-A1 TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY Ribon Therapeutics Inc. (US) 2022-04-27 — — EP disclosed
EP-1500657-A1 Substituted pyrazoles as P38 kinase inhibitors G.D. Searle LLC (US) 2005-01-26 — — EP disclosed
EP-1144403-A1 SUBSTITUED PYRAZOLES AS P38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2001-10-17 — — EP disclosed
WO-2000031063-A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS G.D. SEARLE & CO. (US) 2000-06-02 — — WO disclosed
US-5939436-A Five-membered heteroaromatic compounds as dopamine receptor subtype ligands MERCK SHARP & DOHME LTD. (GB) 1999-08-17 — — US disclosed
WO-1996021660-A1 FIVE-MEMBERED HETEROAROMATIC COMPOUNDS AS DOPAMINE RECEPTOR SUBTYPE LIGANDS MERCK SHARP & DOHME LIMITED (GB) 1996-07-18 — — WO disclosed
Send feedback